Transcatheter Embolization and Occlusion Devices | US | 2018 | Market Analysis
The US market for TEO devices is dynamic and complex, driven by continual device improvement and adoption of new, innovative products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in the US across a 10-year period.
The INR flow-diverting device market continues to be one of the fastest-growing markets in the TEO device space.
How does the continued adoption of flow-diverting devices impact the INR embolization coil and INR coiling-assist markets?
How will emerging competitors impact the INR flow-diverting device market?
The PV plug market is dynamic, with new companies and products entering this space.
How has the competitive landscape changed with the emergence of new competitors?
Will new PV plug designs be able to compete with traditional PV plugs?
Companies with broad TEO product portfolios are more successful in this market.
Which competitors are using the breadth of their product portfolios to secure TEO market shares?
How are competitors expanding their offerings through new product innovation and/or acquisition to capture more overall TEO market share?
The TEO device market has seen multiple acquisitions in 2016 and 2017.
Which markets are most affected by these acquisitions?
How will these acquisitions affect TEO device manufacturers’ competitive strategies?
Which competitors stand to gain or lose the most from these acquisitions?
